| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.34 | 9e-12 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0007 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.0009 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.002 |